Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clarifying immunogenicity and switching for oncology biosimilars

Date

27 Sep 2019

Session

Biosimilars use in oncology: Clarifying concepts

Presenters

Pekka Kurki

Authors

P. Kurki

Author affiliations

  • Clinical Immunology Department, University of Helsinki, FIN-00014 - Helsinki/FI
More

Resources

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings